Don C. Rockey
Affiliations: | Duke University, Durham, NC |
Area:
Cell Biology, Molecular BiologyGoogle:
"Don Rockey"Collaborators
Sign in to add collaboratorRichard T Premont | collaborator | 2000- | MUSC (Chemistry Tree) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Liu S, Premont RT, Park KH, et al. (2022) β-PIX cooperates with GIT1 to regulate eNOS in sinusoidal endothelial cells. American Journal of Physiology. Gastrointestinal and Liver Physiology |
Liu S, Luttrell LM, Premont RT, et al. (2020) Reply to Schierwagen et al.: β-Arrestins in liver disease. Proceedings of the National Academy of Sciences of the United States of America. 117: 27085-27086 |
Hoofnagle JH, Bonkovsky HL, Phillips EJ, et al. (2020) HLA-B*35:01 and Green Tea Induced Liver Injury. Hepatology (Baltimore, Md.) |
Qi X, Wang J, Li X, et al. (2020) Clinical course of COVID-19 in patients with pre-existing decompensated cirrhosis: initial report from China. Hepatology International |
Qi X, Liu Y, Wang J, et al. (2020) Clinical course and risk factors for mortality of COVID-19 patients with pre-existing cirrhosis: a multicentre cohort study. Gut |
Liu S, Luttrell LM, Premont RT, et al. (2020) β-Arrestin2 is a critical component of the GPCR-eNOS signalosome. Proceedings of the National Academy of Sciences of the United States of America |
Khalifa A, Rockey DC. (2020) The utility of liver biopsy in 2020. Current Opinion in Gastroenterology |
Khalifa A, Rockey DC. (2020) Lower Gastrointestinal Bleeding in Patients With Cirrhosis-Etiology and Outcomes. The American Journal of the Medical Sciences |
Shi Z, Ren M, Rockey DC. (2020) Myocardin and myocardin-related transcription factor-A synergistically mediate actin cytoskeletal dependent inhibition of liver fibrogenesis. American Journal of Physiology. Gastrointestinal and Liver Physiology |
Prakash S, Rockey DC. (2020) 1006 PREDICTORS OF POOR FIBROSIS REGRESSION AFTER DIRECT ACTING ANTIVIRAL THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C AND CIRRHOSIS Gastroenterology. 158: S-1302-S-1303 |